A researcher at the University of Oklahoma College of Pharmacy at OU Health Sciences is playing a key role in a preclinical trial that is testing a non-addictive drug to treat post-traumatic stress disorder and alcohol use disorder. Recent findings from the trial are promising: The drug reduces symptoms of post-traumatic stress disorder like anxiety and increased pain sensitivity, while also decreasing alcohol consumption.